Panagora Asset Management
VRDN icon

Panagora Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Panagora Asset Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.14M Sell
55,264
-269,394
-83% -$5.75M ﹤0.01% 768
2026
Q2 		$5.96M Buy
324,658
+10,958
+3% +$177K 0.02% 426
2026
Q1 		$6.14M Sell
313,700
-11,046
-3% -$328K 0.02% 381
2025
Q4 		$10.1M Sell
324,746
-52,965
-14% -$1.45M 0.04% 292
2025
Q3 		$8.15M Buy
377,711
+25,859
+7% +$466K 0.03% 298
2025
Q2 		$4.92M Sell
351,852
-2,887
-0.8% -$39.2K 0.02% 336
2025
Q1 		$4.78M Buy
354,739
+101,717
+40% +$1.73M 0.02% 345
2024
Q4 		$4.85M Buy
253,022
+84,589
+50% +$1.84M 0.02% 346
2024
Q3 		$3.83M Buy
+168,433
New +$2.75M 0.02% 395
2020
Q3 		– Sell
-151
Closed -$3K – 2764
2020
Q2 		$3K Hold
151
– – ﹤0.01% 2447
2020
Q1 		$1K Hold
151
– – ﹤0.01% 2456
2019
Q4 		$1K Hold
151
– – ﹤0.01% 2416
2019
Q3 		$2K Buy
+151
New +$3.34K ﹤0.01% 2377
2018
Q3 		– Sell
-383
Closed -$37K – 2470
2018
Q2 		$37K Sell
383
-212
-36% -$22.4K ﹤0.01% 2097
2018
Q1 		$63K Hold
595
– – ﹤0.01% 1967
2017
Q4 		$93K Sell
595
-16
-3% -$2.04K ﹤0.01% 1899
2017
Q3 		$84K Sell
611
-153
-20% -$25.7K ﹤0.01% 1930
2017
Q2 		$148K Buy
764
+743
+3,538% +$125K ﹤0.01% 1760
2017
Q1 		$4K Buy
+21
New +$3.62K ﹤0.01% 2314

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Panagora Asset Management's VRDN Position: Q3 2026 in Review

Panagora Asset Management reduced its Viridian Therapeutics (VRDN) stake by 83% in Q3 2026, selling an estimated $5.75M and leaving 55,264 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Panagora Asset Management first reported a position in VRDN in Q1 2017 and has held it in 19 quarters since. The position peaked at $10.1M in Q4 2025. 121 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.

  • Panagora Asset Management held 55,264 shares of Viridian Therapeutics worth $1.14M as of Q3 2026.
  • Panagora Asset Management sold 269,394 Viridian Therapeutics shares in Q3 2026, an estimated $5.75M.
  • Viridian Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q3 2026, its #768 holding.
  • Panagora Asset Management first reported a position in Viridian Therapeutics in Q1 2017 and has held it in 19 quarters since.
  • Panagora Asset Management's Viridian Therapeutics position peaked at $10.1M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.

Based on Panagora Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.